David M. Asarnow

1.1k total citations · 1 hit paper
10 papers, 929 citations indexed

About

David M. Asarnow is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, David M. Asarnow has authored 10 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in David M. Asarnow's work include T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (3 papers). David M. Asarnow is often cited by papers focused on T-cell and B-cell Immunology (5 papers), Immune Cell Function and Interaction (5 papers) and Immunotherapy and Immune Responses (3 papers). David M. Asarnow collaborates with scholars based in United States and Russia. David M. Asarnow's co-authors include James P. Allison, Robert E. Tigelaar, Philip W. Tucker, William A. Kuziel, Leo Lefrançois, Thomas Goodman, David H. Raulet, Dragana Cado, Yi Zhang and Richard D. Minshall and has published in prestigious journals such as Nature, Cell and Immunity.

In The Last Decade

David M. Asarnow

10 papers receiving 915 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Limited diversity of γδ antigen receptor genes of thy-1+ dendritic epidermal cells

1988 451 citations David M. Asarnow, William A. Kuziel et al. Cell profile →

Peers

Countries citing papers authored by David M. Asarnow

Since Specialization

Citations

This map shows the geographic impact of David M. Asarnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Asarnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Asarnow more than expected).

Fields of papers citing papers by David M. Asarnow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Asarnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Asarnow. The network helps show where David M. Asarnow may publish in the future.

Co-authorship network of co-authors of David M. Asarnow

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Asarnow. A scholar is included among the top collaborators of David M. Asarnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Asarnow. David M. Asarnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Validation and international regulatory experience for a mycoplasma touchdown PCR assay 2010 ·Biologicals ·David M. Asarnow, Ann L. Warford, (unknown), (unknown), (unknown), (unknown), (unknown), Mark E. Goldman, (unknown)	11
2	Receptor for Activated C-Kinase (RACK-1), a WD Motif-Containing Protein, Specifically Associates with the Human Type I IFN Receptor 2000 ·The Journal of Immunology ·Ed Croze, Anna Usacheva, David M. Asarnow, Richard D. Minshall, H. Daniel Perez, Oscar R. Colamonici	45
3	The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents 2000 ·Journal of Neuroimmunology ·Harald Dinter, Jenny Tse, Meredith Halks‐Miller, David M. Asarnow, James Onuffer, Daryl Faulds, Branislava Mitrovic, G. Kirsch, Henry Laurent, (unknown), Dieter Seidelmann, Eckhard Ottow, Herbert H. Schneider, Vincent K. Tuohy, H. Wachtel, Hector D. Perez	43
4	The role of short homology repeats and TdT in generation of the invariant γδ antigen receptor repertoire in the fetal thymus 1995 ·Immunity ·Yi Zhang, Dragana Cado, David M. Asarnow, Toshihisa Komori, Frederick W. Alt, David H. Raulet, James P. Allison	57
5	Selection is not required to produce invariant T-cell receptor γ-gene junctional sequences 1993 ·Nature ·David M. Asarnow, Dragana Cado, David H. Raulet	88
6	γδ T Cells in Murine Epithelia: Origin, Repertoire, and Function 1991 ·Advances in experimental medicine and biology ·James P. Allison, David M. Asarnow, Mark Bonyhadi, (unknown), Wendy L. Havran, (unknown), Janelle A. Noble	16
7	Distinct antigen receptor repertoires of two classes of murine epithelium-associated T cells 1989 ·Nature ·David M. Asarnow, Thomas Goodman, Leo Lefrançois, James P. Allison	189
8	Limited diversity of γδ antigen receptor genes of thy-1+ dendritic epidermal cells breakdown → 1988 ·Cell ·David M. Asarnow, William A. Kuziel, (unknown), Robert E. Tigelaar, Philip W. Tucker, James P. Allison	451
9	γδ Antigen receptors of Thy-1 + dendritic epidermal cells: Implications for thymic differentiation 1988 ·Immunologic Research ·James P. Allison, (unknown), David M. Asarnow, Robert E. Tigelaar, Philip W. Tucker, Mark Bonyhadi	5
10	Early expression of vimenti in human mammary cultures 1985 ·In Vitro Cellular & Developmental Biology - Plant ·Shanaz H. Dairkee, (unknown), David M. Asarnow, Helene S. Smith, Adeline J. Hackett	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact